Cargando…

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study

OBJECTIVE: To evaluate the efficacy and safety of conversion to lacosamide 400 mg/day monotherapy in adults with focal epilepsy. METHODS: This historical-controlled, double-blind study (NCT00520741) enrolled patients aged 16–70 years on stable doses of 1–2 antiepileptic drugs (AEDs) and experiencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wechsler, Robert T, Li, George, French, Jacqueline, O'Brien, Terence J, D'Cruz, O'Neill, Williams, Paulette, Goodson, Robin, Brock, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2014
Materias:	Full-Length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477913/ https://www.ncbi.nlm.nih.gov/pubmed/24915838 http://dx.doi.org/10.1111/epi.12681

Ejemplares similares

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017)

A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study
por: Runge, Uwe, et al.
Publicado: (2015)

Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
por: Vossler, David G, et al.
Publicado: (2020)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
por: Jaiswal, Binaya Kumar, et al.
Publicado: (2023)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Lacosamide monotherapy in clinical practice: A retrospective chart review
por: Villanueva, V., et al.
Publicado: (2018)

Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
por: Trinka, Eugen, et al.
Publicado: (2020)

Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
por: Liu, Wenyu, et al.
Publicado: (2023)

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)

Effects of lacosamide and carbamazepine on lipids in a randomized trial
por: Mintzer, Scott, et al.
Publicado: (2020)

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial
por: O’Brien, Terence J., et al.
Publicado: (2022)

Randomized trial of add‐on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy
por: Borges, Karin, et al.
Publicado: (2019)

Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015)

The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial
por: Ben‐Menachem, Elinor, et al.
Publicado: (2021)

Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses
por: Doğan, Ebru Apaydın, et al.
Publicado: (2018)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
por: Driessen, J.T., et al.
Publicado: (2022)

Cathodal transcranial direct‐current stimulation for treatment of drug‐resistant temporal lobe epilepsy: A pilot randomized controlled trial
por: Zoghi, Maryam, et al.
Publicado: (2016)

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
por: Rudà, Roberta, et al.
Publicado: (2020)

Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022)

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America
por: Sperling, Michael R., et al.
Publicado: (2015)

Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients
por: Lu, Yan-Ting, et al.
Publicado: (2022)

Seven tesla MRI improves detection of focal cortical dysplasia in patients with refractory focal epilepsy
por: Veersema, Tim J., et al.
Publicado: (2017)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials
por: Johnson, Martin E., et al.
Publicado: (2021)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023)

Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
por: Kellinghaus, Christoph
Publicado: (2009)

Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
por: DeGiorgio, Andrew C., et al.
Publicado: (2012)

Lacosamide Precipitated Neutropenia in a Patient with Bipolar Disorder and Comorbid Epilepsy
por: Rao, Naren P., et al.
Publicado: (2018)

Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1sgcn24prjjvkm89tpq809uppq